These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5851109)

  • 1. Myelomatosis with 'myeloma cells' in the urine.
    Khan AB; Prasad H; Agarwal RP; Verma S
    J Indian Med Assoc; 1965 Nov; 45(10):553-4. PubMed ID: 5851109
    [No Abstract]   [Full Text] [Related]  

  • 2. Exfoliated 'myeloma cells' in the urine of a case of multiple myelomatosis.
    PROWSE CM; BLECHER TE
    J Clin Pathol; 1962 Mar; 15(2):136-40. PubMed ID: 14489010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The development of plasma cells in case of myelomatosis (author's transl)].
    Bichel J; Jensen KB
    Folia Clin Int (Barc); 1975 Mar; 25(3):187-8. PubMed ID: 1140480
    [No Abstract]   [Full Text] [Related]  

  • 4. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased osteoblastic activity in myelomatosis.
    Wong KF; So CC; Chan JK
    Br J Haematol; 2000 Oct; 111(1):1. PubMed ID: 11091176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmocytic meningitis in multiple myeloma. An anatomo-clinical observation].
    Boudouresques G; Pellissier JF; Gastaut JA; Delpuech F; Habib M; Cros D; Boudouresques J
    Ann Med Interne (Paris); 1983; 134(2):117-22. PubMed ID: 6881800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cytology in multiple myeloma.
    Patil S; Schwarer A; McLean C
    Cytopathology; 2008 Apr; 19(2):130-1. PubMed ID: 17488260
    [No Abstract]   [Full Text] [Related]  

  • 8. Auer rod-like inclusions in myeloma cells in a patient with IgG multiple myeloma.
    Das S; Kakkar N; Ahuja B; Lal M
    Indian J Pathol Microbiol; 2006 Oct; 49(4):561-3. PubMed ID: 17183855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On myelomatosis.
    HARBOE NM
    Acta Haematol; 1958; 20(1-4):27-33. PubMed ID: 13582543
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proteinuria with myelomatosis (Kahler's disease)].
    WIEME RJ
    Belg Tijdschr Geneesk; 1956 Aug; 12(17):969-71. PubMed ID: 13363782
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nature of plasma cell inclusions in multiple myeloma].
    Beliakova TA; Podgurskaia RA; Ushakova EA; Liubetskiĭ VB; Kharchenko MF
    Probl Gematol Pereliv Krovi; 1980 Apr; 25(4):21-6. PubMed ID: 7384017
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple myeloma manifested by plasmocytic laryngeal localization].
    Colbert N; Vacher S; Peytral C; Merlier J; Prot C; Jacob A
    Ann Otolaryngol Chir Cervicofac; 1983; 100(8):599-601. PubMed ID: 6670812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The bromodeoxyuridine index in multiple myeloma. I. Relation with selected laboratory indicators of the disease].
    Scudla V; Ordeltová M; Bacovský J; Spidlová A; Budíková M; Kubalová D; Zivná J
    Vnitr Lek; 1996 Jul; 42(7):458-62. PubMed ID: 8928421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoldering indolent multiple myeloma].
    Andreeva NE
    Ter Arkh; 1983; 55(8):55-9. PubMed ID: 6635957
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmacytic infiltrates of the skin as the first clinical manifestation of multiple myeloma.
    Cholongitas E; Pipili C; Katsogridakis K; Zouli C; Rellos K; Dasenaki M; Kaklamanis L
    Int J Dermatol; 2007 Dec; 46(12):1323-4. PubMed ID: 18173542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multiple myeloma and diffuse decalcifying myelomatosis. Atlas of Clinicial Radiology, No.45].
    LIEVRE JA
    Presse Med (1893); 1955 Apr; 63(28):1-4. PubMed ID: 14384752
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.